Table 3. List of some FDA-approved nanomedicines for anticancer therapeutics.

Name of Nano-formulation	Active Drug Loaded	Nanomaterial Type	Cancer Therapy	Year of Approval	References
Doxil/Calex	Doxorubicin	Liposome (PEGylated)	HIV-associated Kaposi’s sarcoma, ovarian cancer, metastatic breast cancer, and multiple myeloma	1995	[3]
DaunoXome/Galen	Daunorubicin	Liposome (PEGylated)	HIV-associated Kaposi’s sarcoma	1996	[5]
DepoCyt	Cytosine arabinoside (cytarabine)	Liposome	Neoplastic meningitis	1999	[3]
Eligard	Leuprolide acetate	Polymer	Prostate cancer	2002	[10]
Abraxane	Paclitaxel	Nanoparticle albumin-bound (Nab)	Advanced non-small cell lung cancer, metastatic pancreatic cancer, and metastatic breast cancer	2005	[8,9]
Marqibo	Vincristine	Liposome (non-PEGylated)	Philadelphia chromosome-negative acute lymphoblastic leukemia	2012	[5,8]
Abraxane	Paclitaxel + Gemcitabine	Nab	Metastatic pancreatic cancer	2013	[8]
Onivyde/MM-398/Merrimack	Irinotecan	Liposome (PEGylated)	Metastatic pancreatic cancer (second line)	2015	[3,5]